STRATA SKIN SCIENCES INC

NASDAQ: SSKN (Strata Skin Sciences, Inc.)

Kemas kini terakhir: 04 May, 12:29AM

2.63

-0.07 (-2.59%)

Penutupan Terdahulu 2.70
Buka 2.65
Jumlah Dagangan 2,398
Purata Dagangan (3B) 2,583
Modal Pasaran 10,970,151
Harga / Jualan (P/S) 0.200
Harga / Buku (P/B) 5.77
Julat 52 Minggu
2.51 (-4%) — 4.70 (78%)
Tarikh Pendapatan 5 May 2025 - 9 May 2025
Margin Keuntungan -27.22%
Margin Operasi (TTM) -29.58%
EPS Cair (TTM) -2.27
Pertumbuhan Hasil Suku Tahunan (YOY) 0.90%
Jumlah Hutang/Ekuiti (D/E MRQ) 614.35%
Nisbah Semasa (MRQ) 1.05
Aliran Tunai Bebas Leveraj (LFCF TTM) 1.80 M
Pulangan Atas Aset (ROA TTM) -7.60%
Pulangan Atas Ekuiti (ROE TTM) -151.23%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Devices (US) Bercampur Bercampur
Medical Devices (Global) Bercampur Bercampur
Stok Strata Skin Sciences, Inc. Bercampur Menurun

AISkor Stockmoo

-1.2
Konsensus Penganalisis NA
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal 2.5
Osilator Teknikal -4.0
Purata -1.17

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
SSKN 11 M - - 5.77
QDEL 2 B - - 0.930
BBNX 1 B - - 4.54
AHCO 1 B - 17.44 0.780
IART 1 B - - 1.01
INMD 967 M - 6.85 1.40

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Sektor Healthcare
Industri Medical Devices
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 4.02%
% Dimiliki oleh Institusi 64.08%

Pemilikan

Nama Tarikh Syer Dipegang
Financial Perspectives, Inc 31 Mar 2025 101

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
13 Nov 2025 Pengumuman STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
06 Nov 2025 Pengumuman STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
05 Nov 2025 Pengumuman STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update
28 Oct 2025 Pengumuman STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements
20 Oct 2025 Pengumuman STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
14 Oct 2025 Pengumuman Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides
03 Oct 2025 Pengumuman Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis
30 Sep 2025 Pengumuman STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis
22 Sep 2025 Pengumuman New Peer Reviewed Publication of Combination Therapy in Vitiligo with STRATA Skin Sciences’ Excimer Laser and JAK Inhibitors Demonstrated Superior Safety and Unprecedented Response Rates, Providing Continued Validation of Personalized Medicine Approach

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda